An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Description

The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.

Conditions

Rectal Cancer, Self Efficacy

Talk to us

Study Overview

On this page

Study Details

Study overview

The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.

PATHWAYS: An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Condition
Rectal Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02114

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age≥18 years
  • 2. Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
  • 3. Able to complete study procedures English or with the assistance of an interpreter
  • 1. Comorbid health condition that would interfere with study participation, as identified by cancer care team
  • 2. Has undergone treatment for a prior colorectal cancer

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Massachusetts General Hospital,

Kelsey Lau-Min, MD, MSCE, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2028-12